Atomo Diagnostics (ASX:AT1) 1-Year Share Buyback Ratio: -26.70% (As of Dec. 2025 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Atomo Diagnostics 1-Year Share Buyback Ratio?

Atomo Diagnostics ASX:AT1 +5.88% 1-Year Share Buyback Ratio is -26.70 as of Dec. 2025. The stock has 4 warning signs investors should review. Among 539 Medical Devices & Instruments companies, Atomo Diagnostics ranks worse than 79.96% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Atomo Diagnostics's current 1-Year Share Buyback Ratio was -26.70%.

ASX:AT1's 1-Year Share Buyback Ratio is ranked worse than
79.96% of 539 companies
in the Medical Devices & Instruments industry
Industry Median: -2.5 vs ASX:AT1: -26.70

Atomo Diagnostics  (ASX:AT1) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Atomo Diagnostics 1-Year Share Buyback Ratio Related Terms

ASX:AT1 vs ABT, SYK, MDT: 1-Year Share Buyback Ratio Comparison

For the Medical Devices subindustry, Atomo Diagnostics's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Atomo Diagnostics 1-Year Share Buyback Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Atomo Diagnostics's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Atomo Diagnostics's 1-Year Share Buyback Ratio falls into.


Atomo Diagnostics 1-Year Share Buyback Ratio Calculation

Atomo Diagnostics's 1-Year Share Buyback Ratio for the quarter that ended in Dec. 2025 is calculated as

1-Year Share Buyback Ratio=(Shares Outstanding (EOP) (Dec. 2024 ) - Shares Outstanding (EOP) (Dec. 2025 )) / Shares Outstanding (EOP) (Dec. 2024 )
=(639.202 - 810.175) / 639.202
=-26.7%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 1-Year Share Buyback Ratio of -26.70 mean?
Atomo Diagnostics (ASX:AT1) has a 1-Year Share Buyback Ratio of -26.70 as of Dec. 2025. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Atomo Diagnostics and its competitors. According to the industry distribution chart, Atomo Diagnostics ranks #431 out of 539 companies in the Medical Devices & Instruments industry, placing it in the top 80%.
Is Atomo Diagnostics' 1-Year Share Buyback Ratio too high?
Atomo Diagnostics' current 1-Year Share Buyback Ratio is -26.70. Based on the distribution chart, Atomo Diagnostics ranks #431 out of 539 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Atomo Diagnostics' 1-Year Share Buyback Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Atomo Diagnostics ranks #431 out of 539 companies for 1-Year Share Buyback Ratio. This places Atomo Diagnostics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Medical Devices & Instruments company?
A good 1-Year Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Atomo Diagnostics and its competitors. Atomo Diagnostics's current 1-Year Share Buyback Ratio is -26.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atomo Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Atomo Diagnostics (ASX:AT1) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.02 — trading 10% below its estimated fair value. The current 1-Year Share Buyback Ratio is -26.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For Atomo Diagnostics (ASX:AT1), the current 1-Year Share Buyback Ratio is -26.70 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atomo Diagnostics Business Description

Address 3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.